{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:39:51Z","timestamp":1794620391657,"version":"4.9.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-13583-5","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T07:05:25Z","timestamp":1738220725000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Serum cardiac and inflammatory biomarker levels following chemotherapy among female patients with breast cancer attending at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia"],"prefix":"10.1186","volume":"25","author":[{"given":"Muluabay","family":"Getie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biset Asrade","family":"Mekonnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Seifu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonas","family":"Mulugeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon","family":"Tebeje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chernet","family":"Tafere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmare","family":"Amuamuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,30]]},"reference":[{"issue":"1","key":"13583_CR1","first-page":"e002661","volume":"9","author":"MW Bloom","year":"2016","unstructured":"Bloom MW, Hamo CE, Cardinale D, Ky B, Nohria A, Baer L, Skopicki H, Lenihan DJ, Gheorghiade M, Lyon AR. Cancer therapy\u2013related cardiac dysfunction and heart failure: part 1: definitions, pathophysiology, risk factors, and imaging. Circulation: Heart Fail. 2016;9(1):e002661.","journal-title":"Circulation: Heart Fail"},{"issue":"4","key":"13583_CR2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3322\/caac.21341","volume":"66","author":"G Curigliano","year":"2016","unstructured":"Curigliano G, Cardinale D, Dent S, Criscitiello C, Aseyev O, Lenihan D, Cipolla CM. Cardiotoxicity of anticancer treatments: epidemiology, detection, and management. Cancer J Clin. 2016;66(4):309\u201325.","journal-title":"Cancer J Clin"},{"issue":"3","key":"13583_CR3","first-page":"135","volume":"87","author":"M Csapo","year":"2014","unstructured":"Csapo M, Lazar L. Chemotherapy-induced cardiotoxicity: pathophysiology and prevention. Clujul Med. 2014;87(3):135.","journal-title":"Clujul Med"},{"key":"13583_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11936-014-0312-7","volume":"16","author":"LC Magnano","year":"2014","unstructured":"Magnano LC, Mart\u00ednez Cibrian N, Andrade Gonz\u00e1lez X, Bosch X. Cardiac complications of chemotherapy: role of prevention. Curr Treat Options Cardiovasc Med. 2014;16:1\u201315.","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"5","key":"13583_CR5","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1309\/AJCPB66LRIIVMQDR","volume":"130","author":"A Dolci","year":"2008","unstructured":"Dolci A, Dominici R, Cardinale D, Sandri MT, Panteghini M. Biochemical markers for prediction of chemotherapy-induced cardiotoxicity: systematic review of the literature and recommendations for use. Am J Clin Pathol. 2008;130(5):688\u201395.","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"13583_CR6","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.jacc.2013.10.061","volume":"63","author":"B Ky","year":"2014","unstructured":"Ky B, Putt M, Sawaya H, French B, Januzzi JL, Sebag IA, Plana JC, Cohen V, Banchs J, Carver JR. Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab. J Am Coll Cardiol. 2014;63(8):809\u201316.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"13583_CR7","first-page":"231","volume":"9","author":"HA Al-Hadi","year":"2009","unstructured":"Al-Hadi HA, Fox KA. Cardiac markers in the early diagnosis and management of patients with acute coronary syndrome. Sultan Qaboos Univ Med J. 2009;9(3):231.","journal-title":"Sultan Qaboos Univ Med J"},{"key":"13583_CR8","doi-asserted-by":"crossref","unstructured":"Henri C, Heinonen T, Tardif J-C. The role of biomarkers in decreasing risk of cardiac toxicity after cancer therapy: supplementary issue: biomarkers and their essential role in the development of personalised therapies (A). Biomarkers in cancer 2016, 8:BIC. S31798.","DOI":"10.4137\/BIC.S31798"},{"issue":"4","key":"13583_CR9","first-page":"309","volume":"29","author":"J Horacek","year":"2007","unstructured":"Horacek J, Pudil R, Jebavy L, Tichy M, Zak P, Maly J. Assessment of anthracycline-induced cardiotoxicity with biochemical markers. Exp Oncol. 2007;29(4):309\u201313.","journal-title":"Exp Oncol"},{"key":"13583_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.31482\/mmsl.2011.017","volume":"80","author":"JM Horacek","year":"2011","unstructured":"Horacek JM. Biomarkers of cardiac injury in detection of cardiotoxicity induced by chemotherapeutic agents. Mil Med Sci Lett. 2011;80:103\u201317.","journal-title":"Mil Med Sci Lett"},{"key":"13583_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2288-3-27","volume":"3","author":"J Miles","year":"2003","unstructured":"Miles J. A framework for power analysis using a structural equation modelling procedure. BMC Med Res Methodol. 2003;3:1\u201311.","journal-title":"BMC Med Res Methodol"},{"key":"13583_CR12","first-page":"327","volume":"4","author":"R Erdim","year":"2009","unstructured":"Erdim R, Celiker A, Gemici G, Tokay S, \u00dclfer G, Dede F, Turhal S, Oktay A. Cardiac troponin T for early detection of cardiotoxicity in breast cancer patients treated with epirubicin. Cent Eur J Med. 2009;4:327\u201330.","journal-title":"Cent Eur J Med"},{"key":"13583_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-018-4015-4","volume":"18","author":"P Fr\u00e8res","year":"2018","unstructured":"Fr\u00e8res P, Bouznad N, Servais L, Josse C, Wenric S, Poncin A, Thiry J, Moonen M, Oury C, Lancellotti P. Variations of circulating cardiac biomarkers during and after anthracycline-containing chemotherapy in breast cancer patients. BMC Cancer. 2018;18:1\u20139.","journal-title":"BMC Cancer"},{"issue":"3","key":"13583_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1179\/102453312X13376952196412","volume":"17","author":"LM Sherief","year":"2012","unstructured":"Sherief LM, Kamal AG, Khalek E, Kamal NM, Soliman AA, Esh AM. Biomarkers and early detection of late onset anthracycline-induced cardiotoxicity in children. Hematology. 2012;17(3):151\u20136.","journal-title":"Hematology"},{"issue":"5","key":"13583_CR15","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1093\/annonc\/mdi152","volume":"16","author":"S Kilickap","year":"2005","unstructured":"Kilickap S, Barista I, Akgul E, Aytemir K, Aksoyek S, Aksoy S, Celik I, Kes S, Tekuzman G. cTnT can be a useful marker for early detection of anthracycline cardiotoxicity. Ann Oncol. 2005;16(5):798\u2013804.","journal-title":"Ann Oncol"},{"key":"13583_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2193-1801-3-620","volume":"3","author":"K Katsurada","year":"2014","unstructured":"Katsurada K, Ichida M, Sakuragi M, Takehara M, Hozumi Y, Kario K. High-sensitivity troponin T as a marker to predict cardiotoxicity in breast cancer patients with adjuvant trastuzumab therapy. Springerplus. 2014;3:1\u20137.","journal-title":"Springerplus"},{"issue":"17","key":"13583_CR17","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1093\/jnci\/djs317","volume":"104","author":"EJA Bowles","year":"2012","unstructured":"Bowles EJA, Wellman R, Feigelson HS, Onitilo AA, Freedman AN, Delate T, Allen LA, Nekhlyudov L, Goddard KA, Davis RL. Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. J Natl Cancer Inst. 2012;104(17):1293\u2013305.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"13583_CR18","first-page":"102","volume":"10","author":"R-Y Xu","year":"2013","unstructured":"Xu R-Y, Zhu X-F, Yang Y, Ye P. High-sensitive cardiac troponin T. J Geriatric Cardiology: JGC. 2013;10(1):102.","journal-title":"J Geriatric Cardiology: JGC"},{"issue":"3","key":"13583_CR19","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1161\/01.CIR.0000053730.47739.3C","volume":"107","author":"PM Ridker","year":"2003","unstructured":"Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107(3):363\u20139.","journal-title":"Circulation"},{"issue":"8","key":"13583_CR20","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1161\/01.ATV.0000024222.06463.21","volume":"22","author":"MJ J\u00e4rvisalo","year":"2002","unstructured":"J\u00e4rvisalo MJ, Harmoinen A, Hakanen M, Paakkunainen U, Viikari J, Hartiala J, Lehtim\u00e4ki T, Simell O, Raitakari OT. Elevated serum C-reactive protein levels and early arterial changes in healthy children. Arterioscler Thromb Vasc Biol. 2002;22(8):1323\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"13583_CR21","first-page":"595","volume":"9","author":"K Furumoto","year":"2022","unstructured":"Furumoto K, Fujitani N, Nohara M, Hata A. Comparison of Analytical values after changing to the international standardized method for Lactate Dehydrogenase and Alkaline phosphatase measurements in mouse and rat. Veterinary Sci. 2022;9(11):595.","journal-title":"Veterinary Sci"},{"key":"13583_CR22","first-page":"572","volume":"36","author":"W Stein","year":"1985","unstructured":"Stein W. Strategie Der klinisch-chemischen Diagnostik Des Frischen myokardinfarkts. Med Welt. 1985;36:572\u20137.","journal-title":"Med Welt"},{"key":"13583_CR23","doi-asserted-by":"crossref","unstructured":"Thomas L, M\u00fcller M, Schumann G, Weidemann G, Klein G, Lunau S, Pick K-H, Sonntag O. Consensus of DGKL and VDGH for interim reference intervals on enzymes in serum Konsensus von DGKL und VDGH zu vorl\u00e4ufigen Referenzbereichen f\u00fcr Serumenzyme. LaboratoriumsMedizin 2005, 29(5):301\u2013308.","DOI":"10.1515\/JLM.2005.041"},{"key":"13583_CR24","doi-asserted-by":"publisher","first-page":"e2643","DOI":"10.6061\/clinics\/2021\/e2643","volume":"76","author":"NS Rosa Neto","year":"2021","unstructured":"Rosa Neto NS, Bento JCB, Caparbo VF, Pereira RMR. Increased serum Interleukin-6 and tumor necrosis factor alpha levels in Fabry Disease: correlation with Disease Burden. Clin (Sao Paulo). 2021;76:e2643. https:\/\/doi.org\/10.6061\/clinics\/2021\/e2643. PMID: 34287477; PMCID: PMC8266164.","journal-title":"Clin (Sao Paulo)"},{"issue":"1","key":"13583_CR25","first-page":"74","volume":"6","author":"M Mohammadi","year":"2017","unstructured":"Mohammadi M, Gozashti MH, Aghadavood M, Mehdizadeh MR, Hayatbakhsh MM. Clinical significance of serum IL-6 and TNF-\u03b1 levels in patients with metabolic syndrome. Rep Biochem Mol Biol. 2017;6(1):74\u20139. PMID: 29090232; PMCID: PMC5643447.","journal-title":"Rep Biochem Mol Biol"},{"issue":"12","key":"13583_CR26","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1038\/sj.bjc.6601814","volume":"90","author":"V Michalaki","year":"2004","unstructured":"Michalaki V, Syrigos K, Charles P, Waxman J. Serum levels of IL-6 and TNF-alpha correlate with clinicopathological features and patient survival in patients with prostate cancer. Br J Cancer. 2004;90(12):2312\u20136. https:\/\/doi.org\/10.1038\/sj.bjc.6601814. Erratum in: Brtish Journal of Cancer. 2004; 91(6):1227. PMID: 15150588; PMCID: PMC2409519.","journal-title":"Br J Cancer"},{"issue":"3","key":"13583_CR27","doi-asserted-by":"publisher","first-page":"133","DOI":"10.17294\/2330-0698.1027","volume":"1","author":"CA Bomzer","year":"2014","unstructured":"Bomzer CA. Cardiovascular toxicity of common chemotherapy drugs used to treat breast cancer: an overview. J Patient-Centered Res Reviews. 2014;1(3):133\u20136.","journal-title":"J Patient-Centered Res Reviews"},{"key":"13583_CR28","doi-asserted-by":"crossref","unstructured":"Blaes AH, Rehman A, Vock DM, Luo X, Menge M, Yee D, Missov E, Duprez D. Utility of high-sensitivity cardiac troponin T in patients receiving anthracycline chemotherapy. Vasc Health Risk Manag 2015:591\u20134.","DOI":"10.2147\/VHRM.S89842"},{"issue":"1","key":"13583_CR29","first-page":"1","volume":"2","author":"S Abate","year":"2016","unstructured":"Abate S, Yilma Z, Assefa M, Tigeneh W. Trends of breast cancer in Ethiopia. Int J Cancer Res Mol Mech. 2016;2(1):1.","journal-title":"Int J Cancer Res Mol Mech"},{"key":"13583_CR30","doi-asserted-by":"crossref","unstructured":"Coughlin SS, Cypel Y. Epidemiology of breast cancer in women. Breast Cancer Metastasis Drug Resistance: Progress Prospects 2013:19\u201334.","DOI":"10.1007\/978-1-4614-5647-6_2"},{"issue":"20","key":"13583_CR31","doi-asserted-by":"publisher","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","volume":"138","author":"K Thygesen","year":"2018","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD. Infarction EGobotJESoCACoCAHAWHFTFftUDoM: fourth universal definition of myocardial infarction (2018). Circulation. 2018;138(20):e618\u201351.","journal-title":"Circulation"},{"issue":"2","key":"13583_CR32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJMoa035153","volume":"351","author":"SE 32 Lipshultz","year":"2004","unstructured":"Lipshultz SE, Rifai N, Dalton VM, Levy DE, Silverman LB, Lipsitz SR, Colan SD, Asselin BL, Barr RD, Clavell LA. The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia. N Engl J Med. 2004;351(2):145\u201353.","journal-title":"N Engl J Med"},{"key":"13583_CR33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/BF02912874","volume":"22","author":"P Nigam","year":"2007","unstructured":"Nigam P. Biochemical markers of myocardial injury. Indian J Clin Biochem. 2007;22:10\u20137.","journal-title":"Indian J Clin Biochem"},{"key":"13583_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11912-017-0564-y","volume":"19","author":"KS Shah","year":"2017","unstructured":"Shah KS, Yang EH, Maisel AS, Fonarow GC. The role of biomarkers in detection of cardio-toxicity. Curr Oncol Rep. 2017;19:1\u20138.","journal-title":"Curr Oncol Rep"},{"key":"13583_CR35","unstructured":"Horacek J, Vasatova M, Tichy M, Pudil R, Jebavy L, Maly J. The use of cardiac biomarkers in detection of cardiotoxicity associated with conventional and high-dose chemotherapy for acute leukemia. Exp Oncol 2010."},{"issue":"10","key":"13583_CR36","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1200\/JCO.2010.30.3404","volume":"30","author":"SE Lipshultz","year":"2012","unstructured":"Lipshultz SE, Miller TL, Scully RE, Lipsitz SR, Rifai N, Silverman LB, Colan SD, Neuberg DS, Dahlberg SE, Henkel JM. Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes. J Clin Oncol. 2012;30(10):1042\u20139.","journal-title":"J Clin Oncol"},{"issue":"6","key":"13583_CR37","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.jacc.2008.04.033","volume":"52","author":"LB Daniels","year":"2008","unstructured":"Daniels LB, Laughlin GA, Clopton P, Maisel AS, Barrett-Connor E. Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study. J Am Coll Cardiol. 2008;52(6):450\u20139.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"13583_CR38","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.hfc.2016.12.006","volume":"13","author":"A Blaes","year":"2017","unstructured":"Blaes A, Prizment A, Koene RJ, Konety S. Cardio-oncology related to heart failure: common risk factors between cancer and cardiovascular disease. Heart Fail Clin. 2017;13(2):367\u201380.","journal-title":"Heart Fail Clin"},{"issue":"2","key":"13583_CR39","first-page":"8","volume":"5","author":"MA Emokpae","year":"2017","unstructured":"Emokpae MA, Nwagbara GO. Serum creatine kinase-MB isoenzyme activity among subjects with uncomplicated essential hypertension: any sex differences. Med Sci. 2017;5(2):8.","journal-title":"Med Sci"},{"key":"13583_CR40","doi-asserted-by":"crossref","unstructured":"Datta S, Pal M, Mitra KGR, Pradhan AK. Evaluation of cardiac biomarkers in detection of Cardiomyopathy Induced by Cardiotoxic Chemotherapeutic Agents. J Cancer Tumor Int 2015:196\u2013205.","DOI":"10.9734\/JCTI\/2015\/19169"},{"issue":"3","key":"13583_CR41","doi-asserted-by":"publisher","first-page":"e32471","DOI":"10.1371\/journal.pone.0032471","volume":"7","author":"LM Brewster","year":"2012","unstructured":"Brewster LM, Coronel CM, Sluiter W, Clark JF, van Montfrans GA. Ethnic differences in tissue creatine kinase activity: an observational study. PLoS ONE. 2012;7(3):e32471.","journal-title":"PLoS ONE"},{"issue":"34","key":"13583_CR42","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.1200\/JCO.2011.36.7045","volume":"29","author":"EA Perez","year":"2011","unstructured":"Perez EA, Suman VJ, Davidson NE, Gralow JR, Kaufman PA, Visscher DW, Chen B, Ingle JN, Dakhil SR, Zujewski J. Sequential versus concurrent trastuzumab in adjuvant chemotherapy for breast cancer. J Clin Oncol. 2011;29(34):4491\u20137.","journal-title":"J Clin Oncol"},{"issue":"4\u20135","key":"13583_CR43","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.clinbiochem.2014.10.013","volume":"48","author":"ES Christenson","year":"2015","unstructured":"Christenson ES, James T, Agrawal V, Park BH. Use of biomarkers for the assessment of chemotherapy-induced cardiac toxicity. Clin Biochem. 2015;48(4\u20135):223\u201335.","journal-title":"Clin Biochem"},{"issue":"2","key":"13583_CR44","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ctrv.2003.07.003","volume":"30","author":"KJ Schimmel","year":"2004","unstructured":"Schimmel KJ, Richel DJ, Van den Brink RB, Guchelaar H-J. Cardiotoxicity of cytotoxic drugs. Cancer Treat Rev. 2004;30(2):181\u201391.","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"13583_CR45","first-page":"16","volume":"9","author":"A Iqubal","year":"2018","unstructured":"Iqubal A, Haque SE, Sharma S, Ansari MA, Khan V, Iqubal MK. Clinical updates on drug-induced cardiotoxicity. Int J Pharm Sci Res. 2018;9(1):16\u201326.","journal-title":"Int J Pharm Sci Res"},{"issue":"10","key":"13583_CR46","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1158\/1078-0432.CCR-10-1359","volume":"17","author":"PG Morris","year":"2011","unstructured":"Morris PG, Chen C, Steingart R, Fleisher M, Lin N, Moy B, Come S, Sugarman S, Abbruzzi A, Lehman R. Troponin I and C-reactive protein are commonly detected in patients with breast cancer treated with dose-dense chemotherapy incorporating trastuzumab and lapatinib. Clin Cancer Res. 2011;17(10):3490\u20139.","journal-title":"Clin Cancer Res"},{"issue":"16","key":"13583_CR47","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1161\/01.CIR.0000096055.62724.C5","volume":"108","author":"P Calabr\u00f3","year":"2003","unstructured":"Calabr\u00f3 P, Willerson JT, Yeh ET. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation. 2003;108(16):1930\u20132.","journal-title":"Circulation"},{"issue":"5","key":"13583_CR48","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.ejca.2003.12.012","volume":"40","author":"J Nuver","year":"2004","unstructured":"Nuver J, Smit AJ, Sleijfer DT, van Gessel AI, van Roon AM, van der Meer J, van den Berg MP, Burgerhof J, Hoekstra H, Sluiter WJ. Microalbuminuria, decreased fibrinolysis, and inflammation as early signs of atherosclerosis in long-term survivors of disseminated testicular cancer. Eur J Cancer. 2004;40(5):701\u20136.","journal-title":"Eur J Cancer"},{"issue":"2","key":"13583_CR49","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1080\/02841860500482225","volume":"45","author":"PJ Perik","year":"2006","unstructured":"Perik PJ, Van Der Graaf WT, De Vries EG, Boomsma F, Messerschmidt J, Van Veldhuisen DJ, Sleijfer DT, Gietema JA. Circulating apoptotic proteins are increased in long-term disease-free breast cancer survivors. Acta Oncol. 2006;45(2):175\u201383.","journal-title":"Acta Oncol"},{"issue":"1","key":"13583_CR50","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1161\/CIRCRESAHA.116.309955","volume":"120","author":"MR Thomas","year":"2017","unstructured":"Thomas MR, Lip GY. Novel risk markers and risk assessments for cardiovascular disease. Circul Res. 2017;120(1):133\u201349.","journal-title":"Circul Res"},{"issue":"3","key":"13583_CR51","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.cyto.2003.10.004","volume":"25","author":"L Pusztai","year":"2004","unstructured":"Pusztai L, Mendoza TR, Reuben JM, Martinez MM, Willey JS, Lara J, Syed A, Fritsche HA, Bruera E, Booser D. Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy. Cytokine. 2004;25(3):94\u2013102.","journal-title":"Cytokine"},{"issue":"10","key":"13583_CR52","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1503\/cmaj\/051291","volume":"173","author":"L 52 Babuin","year":"2005","unstructured":"Babuin L, Jaffe AS. Troponin: the biomarker of choice for the detection of cardiac injury. CMAJ. 2005;173(10):1191\u2013202.","journal-title":"CMAJ"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13583-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-13583-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13583-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T07:05:34Z","timestamp":1738220734000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-13583-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,30]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13583"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-13583-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5288081\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,30]]},"assertion":[{"value":"18 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Before starting data collection and the preliminary study, an ethical clearance letter with protocol number M.Sc.15c\/17 was obtained from the Departmental Research and Ethics Review Committee, Department of Biochemistry, College of Health Sciences, Addis Ababa University. Oral informed consent was obtained from the study participants before data collection, and data collection was initiated after obtaining consent and provision.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"175"}}